Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap3.91B
Enterprise Value4.99B
Trailing P/E27.05
Forward P/E26.26
NHI
(NYSE)National Health Investors, Inc.
$83.01-- (--)
Loading... - Market loading
National Health Investors (NHI) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)10.22
Forward Price/Sales9.10
Price/Book (mrq)2.53
Price/Tangible Book (mrq)2.53
Price/FCF (ttm)17.45
Price/OCF (ttm)16.15
PEG Ratio8.90
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue13.26
EV/Earnings35.10
EV/EBITDA18.06
EV/EBIT24.92
EV/FCF22.64
Stock Price
Current price, 52-week range, and moving averages
Current Price$83.01
1-Day Change1.10%
52-Week High$91.38
52-Week Low$66.41
52-Week Change10.07%
YTD Change6.38%
1-Year Change10.82%
50-Day MA$84.47
200-Day MA$77.84
Avg Volume (30 day)230.93K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding47.05M
Book Value per Share$32.34
Net Cash per Share$-2.24
FCF per Share$4.68
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$89.00
Target Upside/Downside7.22%
Analyst ConsensusBuy
Analyst Count2
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin78.97%
EBITDA Margin (ttm)73.43%
EBIT Margin (ttm)53.22%
Operating Margin (ttm)50.71%
Pretax Margin (ttm)37.41%
Profit Margin (ttm)37.78%
FCF Margin (ttm)58.57%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)9.34%
Return on Assets (ttm)5.08%
Return on Invested Capital (ttm)7.59%
Return on Capital Employed (ttm)7.50%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue376.35M
Gross Profit297.19M
Operating Income190.86M
Pretax Income140.79M
Net Income142.18M
EBITDA276.34M
EBIT194.73M
Diluted EPS$3.02
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow238.22M
Capital Expenditures17.78M
Free Cash Flow220.43M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth12.28%
Dividend Growth1.67%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)2.80B
Cash & Securities (mrq)19.62M
Net Cash (mrq)-105.38M
Net Cash per Share$-2.24
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)1.16B
Working Capital (mrq)185.22M
Total Equity (mrq)1.52B
Book Value per Share$32.34
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)2.48
Quick Ratio (mrq)2.48
Debt/Equity (mrq)0.76
Debt/EBITDA (ttm)4.21
Debt/FCF (ttm)5.28
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$3.66
Dividend Yield4.48%
Payout Ratio (Earnings)121.12%
Payout Ratio (FCF)78.12%
Dividend Growth (YoY)1.67%
Ex-Dividend DateMar 31, 2026
Pay DateMay 1, 2026
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield3.70%
FCF Yield5.73%
Buyback Yield0.00%
Total Shareholder Yield4.48%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score2.09
Piotroski F-Score5/9
Dividend Score41.23
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Lynch Fair Value$9.18
Lynch Upside/Downside-88.77%
Graham Number$46.89
Graham Upside/Downside-42.64%
Frequently Asked Questions About National Health Investors Statistics
What are the key financial metrics for NHI?
National Health Investors, Inc. (NHI) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is NHI's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether National Health Investors is overvalued or undervalued.
How do I read NHI's profitability ratios?
National Health Investors's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do NHI's debt ratios indicate?
The financial health section shows National Health Investors's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is NHI's dividend analysis?
The dividend section covers National Health Investors's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.